[CBC뉴스] 질병관리본부가 화이자 주식회사, 존슨앤드존슨의 코로나 바이러스 백신 수입 계약을 체결했다고 24일 밝혔다. 모더나와는 협상이 진행중이다.
질병관리본부는 J&J의 의약품 부문인 Jansen의 400만 명에서 600만 명분이 추가되었고 2분기부터 접종 준비가 될 것이라고 밝혔다.
South Korea has signed deals with Pfizer Inc and Johnson & Johnson's Janssen to import coronavirus vaccines to cover up to 16 million people, with negotiations between Moderna underway, the Korea Disease Control and Prevention Agency (KDCA) said on Thursday (December 24).
The government faced growing public pressure over their COVID-19 vaccine procurement plans as the country reported its second-highest daily tally of cases on Wednesday (December 23)
The Pfizer and Janssen deals are part of a government plan to buy enough doses from four drugmakers and the global COVAX initiative, backed by the World Health Organization, that will allow immunization of at least 85% of South Korea's population of 52 million. The government had already signed a deal with AstraZeneca Plc, which will be shipped as early as January next year, and is in final talks with Moderna Inc to sign a deal in January to secure 20 million doses.
Korea Disease Control and Prevention Agency (KDCA) said the doses from Janssen - J&J's pharmaceuticals division - were added from the initial amount for 4 million people to 6 million and will be ready for inoculation from the second quarter.
CBC뉴스ㅣCBCNEWS 정종훈 기자 email@example.com